[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"thyroid-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:thyroid-disease":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,39,62,89],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":38},"100620163","impact-of-thyroid-dysfunction-on-liver-function-tests-100620163",false,"NCT07354048","Impact Of Thyroid Dysfunction on Liver Function Tests","Impact Of Thyroid Dysfunction on Liver Function Tests In Sohag University Hospital","Inclusion Criteria:\n\n* All patients between the ages of 20-60 years old either with Hypothyroidism or Hyperthyroidism (controlled on treatment or not) and firstly diagnosed Hypothyroidism or Hyperthyroidism.\n* Euthyroid controls (clinically healthy control subjects were recruited from the general population with the same socio-economic status with the subjects.)\n\nExclusion Criteria:\n\n* Patients aged \\\u003C 20 years old.\n* Patients With Liver Disease.\n* Pregnant and lactating women.\n* Patients with severe infections or sepsis.\n* Patients with Heart Disease.\n* Patients who on drugs that can affect liver function such as phenothiazine, phenylbutazone, methyldopa, among others.","ALL","20 Years","60 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate the effect of thyroid dysfunction on liver function tests.",[25],"Thyroid Disease","RECRUITING","2026-01-20",{"date":29,"type":30},"2026-01-21","ACTUAL",{"date":32,"type":30},"2025-07-14",{"date":34,"type":21},"2026-01-30",{"name":36,"class":37},"Sohag University","OTHER",1,{"id":40,"slug":41,"hasResults":11,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":4,"eligibilityCriteria":45,"healthyVolunteers":11,"sex":16,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":50,"studyType":22,"phases":4,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":38},"100615621","the-effective-blood-concentration-of-ciprofol-100615621","NCT07294989","The Effective Blood Concentration of Ciprofol","Median Effective Concentration of Ciprofol and Its Correlation With Bispectral Index: A Prospective Observational Study","Inclusion Criteria:\n\n* Patients aged 18-65 years\n* Scheduled for elective thyroidectomy\n* ASA physical status classification I-II\n* Willing to participate and providing written informed consent\n\nExclusion Criteria:\n\n* Recent use of sedatives or opioid analgesics\n* Severe hepatic or renal dysfunction defined as:Child-Pugh class C (score ≥10), Creatinine clearance \\\u003C35 mL\u002Fmin ,Requiring preoperative dialysis\n* Significant cardiovascular comorbidities\n* Body mass index ≥35 kg\u002Fm² or \\\u003C18.5 kg\u002Fm²\n* Known hypersensitivity or adverse reactions to propofol\u002Fciprofol\n* Neuropsychiatric disorders including:Alzheimer's disease,History of cerebrovascular events,Traumatic brain injury,Space-occupying brain lesions,Other significant neurological deficits","18 Years","65 Years",{"count":49,"type":21},101,"1 Day","1. Eligible patients were selected and enrolled in the study.\n2. General anesthesia was induced using ciprofol in all participants, with standardized evaluation of consciousness levels during induction.\n3. The patients' pain and cognition are followed up after surgery.",[25],"2026-01-05",{"date":55,"type":30},"2026-01-06",{"date":57,"type":30},"2025-07-01",{"date":59,"type":21},"2026-06-30",{"name":61,"class":37},"Peking University Shenzhen Hospital",{"id":63,"slug":64,"hasResults":11,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":67,"eligibilityCriteria":68,"healthyVolunteers":11,"sex":16,"minAge":46,"maxAge":4,"enrollmentInfo":69,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":80,"lastUpdatePostDateStruct":81,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":38},"100538867","dysphagia-after-thyroidectomy-100538867","NCT06296420","Dysphagia After Thyroidectomy","DYSPHATHYR","Inclusion Criteria:\n\n* Diagnosis of goiter or thyroidectomy.\n\nExclusion Criteria:\n\n* Diagnosis of other neurological disorders or disorders involving the aerodigestive tract that could cause swallowing disorders.\n* Previous surgery of the neck or involving the aerodigestive tract.",{"count":70,"type":21},420,"The goal of this observational study is to develop a questionnaire for measuring swallowing and throat discomfort symptoms in patients with goiter or thyroidectomy, which complies with the model of Rasch and which satisfies the fundamental measurement axioms (e.g., unidimensionality, linearity, generalizability). Developing a scale with such characteristics would provide clinicians and researchers with a reliable tool for assessing the impact of goiter and for measuring the outcomes after surgery.\n\nAlso, the study will assess the psychological impact of goiter and thyroidectomy, as well as the characteristics of the surgical scar after thyroidectomy.\n\nThe questionnaire will be developed in the first phase of the study. Items and response categories will be identified through interviews performed with patients affected by goiter or after thyroidectomy.\n\nIn the following phases of the study, the questionnaire will be administered to patients before and after thyroidectomy.",[73,25],"Goiter",[75,76,77,78,79],"Nodular goiter","Thyroidectomy","Dysphagia","Psychometrics","Rasch analysis","2025-12-17",{"date":82,"type":30},"2025-12-18",{"date":84,"type":30},"2024-01-31",{"date":86,"type":21},"2026-11-30",{"name":88,"class":37},"Istituto Auxologico Italiano",{"id":90,"slug":91,"hasResults":11,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":4,"eligibilityCriteria":95,"healthyVolunteers":11,"sex":16,"minAge":46,"maxAge":4,"enrollmentInfo":96,"targetDuration":4,"studyType":98,"phases":99,"briefSummary":101,"conditions":102,"keywords":103,"overallStatus":108,"whyStopped":4,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":38},"100595063","effect-of-nutrition-education-on-the-quality-of-life-chronic-disease-adaptation-in-patients-with-thyroid-dysfunction-100595063","NCT07027579","Effect of Nutrition Education on the Quality of Life, Chronic Disease Adaptation in Patients With Thyroid Dysfunction","The Effect of Nutrition Education Program on the Quality of Life and Chronic Disease Adaptation in Patients With Thyroid Dysfunction","Inclusion Criteria:\n\n* Not having any physical or mental disabilities\n* Not having received such training before\n* Volunteering to participate in the study\n* Be 18 years of age or older.\n\nExclusion Criteria:\n\n* Being under 18 years of age.\n* Having cognitive dysfunction.\n* Not volunteering to participate in the study.",{"count":97,"type":21},60,"INTERVENTIONAL",[100],"NA","This thesis study is designed to examine the effects of nutrition education provided to individuals with thyroid dysfunction on their quality of life and adaptation to the disease. The data will be collected using the Descriptive Characteristics Form, the Nutrition Attitude Scale, the Quality of Life Scale for Thyroid Patients (ThyPRO), and the Chronic Illness Adherence Scale. The Body Mass Index (BMI) of participating patients will be calculated by the researcher based on measured height and weight. Laboratory values including TSH, free T4, and free T3 will be obtained from the patients' medical records on the day of assessment. Data collection will be conducted in two phases. The study population will consist of all patients diagnosed with thyroid dysfunction who present to Dr. Burhan Nalbantoğlu Hospital. Using the G\\*Power 3.1.9.2 software, the required sample size was calculated prior to data collection with a 95% confidence level. For correlation analysis, an alpha value of 0.05, an effect size of 0.455, and a statistical power of 95% were assumed, resulting in a minimum sample size of 56 participants (30 per group). Accounting for potential data loss, a total of 60 patients (30 per group) are planned to be included in the sample.",[25],[104,105,106,107],"Thyroid Dysfunction","Quality of Life","Chronic Disease Adaptation","Nutrition Education Program","NOT_YET_RECRUITING","2025-06-11",{"date":111,"type":30},"2025-06-18",{"date":113,"type":21},"2025-07-20",{"date":115,"type":21},"2025-12-30",{"name":117,"class":37},"Çanakkale Onsekiz Mart University"]